On 22 June 2026, Central Medical Stores issued a public notice inviting all registered suppliers of medicines — manufacturers, distributors and wholesalers alike — to a meeting at its Gaborone offices the following day. The notice itself was unremarkable: a routine engagement between a procuring entity and its supplier base. But it arrived against a backdrop of public concern, reported in this and other publications, over the availability of medicines in the public health system — concern serious enough that government and industry have met to discuss the terms on which medicines reach public facilities.
There's more to this story
But to keep reading, we need you to subscribe.
Investigative journalism is an indispensable part of a healthy society, but it's also expensive to produce. We are reliant on subscriptions to fund our work, and while you can enjoy most of our stories for free, a small number of premium features are reserved for subscribers.
You can subscribe for one week, a month or a full year - the choice is yours.
Save 77% on an annual subscription. Click here to find out how.
Existing subscribers can log in to keep reading here.
